News

Aehr Test Systems (NASDAQ:AEHR) saw its share price climb by 13.10 percent on Friday as investors began positioning their portfolios ahead of business updates next week. According to the company, Chief Executive Officer Gayn Erickson and Chief Finance Officer Chris Siu are set to participate in meetings with institutional investors at the Lake Street Capital […]

Aehr's record backlog, AI-driven orders and strong fiscal 2027 outlook give it an edge over Cohu despite a higher valuation.

Velo3D, Aehr Test Systems, and Atlassian have all rallied recently on improving revenue, bookings, and AI-driven demand, but each faces distinct risks to sustaining momentum.

Here is how Lam Research (LRCX) and Aehr Test Systems (AEHR) have performed compared to their sector so far this year.

Shares of Aehr Test Systems (NASDAQ:AEHR) are up roughly 8% in Friday midday, after a fresh Wall Street initiation lit another fire under one of 2026’s most explosive small caps. The move extends a year-to-date advance of 510.7% and pushes the stock through its 52-week high of $133.35. Jefferies Buy Rating and $175 Target Fuel ... Aehr Test Systems Soars Again Friday. Shares Now Up More than 500% On the Year.

AEHR's 72.2% surge reflects record bookings, a $100.6M backlog and rising AI demand, but its premium valuation raises the stakes.

The insider's sale followed a 484% one-year total return for the stock.

Aehr Test Systems has surged over 400% this year on a dramatic business transformation, but with a price-to-sales ratio that would make most investors flinch and insiders quietly selling into the rally, the question now is whether the momentum has any room left to run.

The company reported a notable insider sale that reduced their indirect holdings by 21% as the stock surged 470% over the past year.

Both companies are burning cash and trading at steep multiples, but their paths to profitability, and their risks, couldn't be more different.

Aehr Test Systems (AEHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Aehr's record bookings, AI-driven backlog and expanding burn-in portfolio give it the edge over FormFactor for long-term growth.

The stock continues to trade as a proxy for AI semiconductor investment, and for good reason.

STT, AEHR and NBIS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 20, 2026.

KTTA, NTRS, YEXT, AEHR and STT have been added to the Zacks Rank #1 (Strong Buy) List on July 20, 2026.

Shares in Aehr Test Systems Inc. (NASDAQ:AEHR) jumped by 11.6 percent week-on-week, as investors increased their exposure after management posted a highly optimistic outlook for fiscal year 2027, thanks to the continued strong demand for semiconductor testing. In an updated report last week, the company said that it is targeting to grow its revenues during […]

Aehr Test Systems beat quarterly estimates and issued FY2027 revenue guidance of $130-$150 million, backed by a $100.6 million backlog and improved gross margins.

The company's burgeoning order growth is a good indicator of investment in AI processors.

Aehr Test Systems gains analyst support as AI demand boosts growth outlook.

Aehr Test Systems (AEHR) kicked off its latest earnings season with Q4 2026 results that drew fresh attention to the stock, as investors weighed a quarterly profit against a weaker full year. See our latest analysis for Aehr Test Systems. The earnings surprise has been reflected in Aehr Test Systems’ share price, with a 1-day share price return of 21.91% and 7-day share price return of 29.31%. However, the 30-day share price return is down 24.24%. Over the past year, total shareholder return...

The AI chip tester's revenue could triple in fiscal 2027.

Aehr stock soars on blockbuster Q2 earnings and impressive future guidance. But Wall Street sees AEHR shares as overvalued at current levels.

Aehr Test Systems climbed by 21.91 percent on Wednesday to close at $87.79 apiece, after management projected a sharp acceleration in its full-year growth for fiscal 2027, underpinned by a record backlog and the continued strong demand for semiconductor testing solutions in AI infrastructure. In an earnings call on Tuesday, the company said that it […]

Aehr Test Systems (NASDAQ:AEHR) shares jumped 30% after the semiconductor test and burn-in equipment provider reported fiscal fourth-quarter results that exceeded Wall Street expectations and provided a stronger-than-anticipated revenue outlook for fiscal 2027. The company posted adjusted...

AEHR beat fiscal Q4 estimates as AI and data-center demand drives 33.7% revenue growth, record bookings, and margin expansion.

Investing.com -- U.S. stock index futures edged higher on Wednesday after softer inflation data and a strong start to the corporate earnings season boosted investor sentiment, with markets weighing whether resilient corporate profits can continue to support Wall Street’s record rally despite lingering geopolitical risks.

Semiconductor equipment giant ASML beat estimates for the second quarter and raised its outlook for the full year. ASML stock rose on the news.

The semiconductor equipment maker topped quarterly estimates and forecast fiscal 2027 revenue far above Wall Street expectations.

Aehr Test Systems (AEHR) delivered earnings and revenue surprises of +1,200.00% and +0.72%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?

Shares of Aehr Test Systems the designer, manufacturer, and seller of equipment used in the semiconductor industry, were rising late Tuesday after the company reported better-than-expected earnings and revenue. Aehr said bookings were a record $60.7 million for the quarter. Shares were up nearly 28% in late trading, at $92 a share, after closing up 5.9% in regular trading, at $72.01.